EcoDrugPlus

Phosphoinositide-3-Kinase Regulatory Subunit 1

Ensembl ID : ENSBTAG00000010989
Gene Symbol: PIK3R1
111 Enzyme and pathways 5 Cross references
271 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 2

Ensembl ID : ENSBTAG00000002350
Gene Symbol: PIK3R2
81 Enzyme and pathways 5 Cross references
265 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSBTAG00000002979
Gene Symbol: PIK3R3
42 Enzyme and pathways 4 Cross references
288 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSBTAG00000005978
Gene Symbol: PIK3R5
15 Enzyme and pathways 5 Cross references
266 Possible Orthologues:

Phospholipase A2 Group V

Ensembl ID : ENSBTAG00000039122
Gene Symbol: PLA2G5
10 Enzyme and pathways 5 Cross references
128 Possible Orthologues:

Phospholipase A2 Group Vii

Ensembl ID : ENSBTAG00000019315
Gene Symbol: PLA2G7
3 Enzyme and pathways 5 Cross references
218 Possible Orthologues:

Phospholipase A2 Group X

Ensembl ID : ENSBTAG00000021522
Gene Symbol: PLA2G10
10 Enzyme and pathways 5 Cross references
262 Possible Orthologues:

Phospholipase A2, Group Iia (Platelets, Synovial Fluid)

Ensembl ID : ENSBTAG00000005759
Gene Symbol: PLA2G2A
13 Enzyme and pathways 4 Cross references
157 Possible Orthologues:

Phospholipase A2, Group Iia (Platelets, Synovial Fluid)

Ensembl ID : ENSBTAG00000002700
Gene Symbol: PLA2G2A
4 Cross references
158 Possible Orthologues:

Phospholipase A2, Membrane Associated

Ensembl ID : ENSBTAG00000013039
Gene Symbol: LOC615045
4 Cross references
158 Possible Orthologues:

Phosphoribosylglycinamide Formyltransferase, Phosphoribosylglycinamide Synthetase, Phosphoribosylaminoimidazole Synthetase

Ensembl ID : ENSBTAG00000009188
Gene Symbol: GART
4 Enzyme and pathways 5 Cross references
259 Possible Orthologues:

Plasminogen

Ensembl ID : ENSBTAG00000001271
Gene Symbol: PLG
15 Enzyme and pathways 4 Cross references
281 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).